Imagine you are reviewing a client’s portfolio as a research analyst. The client presents a ‘wealth-maximization’ insurance policy that promises both high mortality cover and double-digit equity returns. In your analysis, you attempt to benchmark the product’s performance against a standard Nifty 50 index fund while simultaneously checking if the death benefit matches the client’s actual financial liabilities. You soon realize the product is opaque; the mortality charges are obscured by the investment management fees, and the death benefit is tied to the volatile market performance of the underlying assets.
In professional financial advisory, decoupling these two objectives is not merely a preference; it is a fiduciary necessity. Insurance is a risk-transfer mechanism designed to replace lost income, whereas investing is a wealth-accumulation exercise designed to grow capital. When a single product merges these, the insurer effectively creates a conflict of interest where the cost of protection is often buried within the investment vehicle.
By separating them, you gain the ability to choose a pure, cost-effective term plan for the former and a diversified, transparent mutual fund or direct equity portfolio for the latter.
Consider the case of a young professional in India deciding between a Unit Linked Insurance Plan (ULIP) and a combination of a term plan and a Public Provident Fund (PPF) or ELSS. The ULIP might offer tax benefits, but it often carries high allocation and administrative charges that erode long-term compounding. By contrast, a term plan allows for a high sum assured at a nominal annual premium, leaving the bulk of the client’s surplus for specialized investment instruments.
This approach ensures that the insurance coverage is determined by the client’s human life value, while the investment allocation is governed by their risk appetite and time horizon.
Ultimately, this analytical rigor improves the quality of your recommendations. When you treat the two as distinct, you can objectively evaluate the ‘cost of insurance’—that is, the net cost after stripping away the investment component. If the product fails to provide adequate protection, it is fundamentally unsuitable, regardless of its projected market returns. Maintaining this distinction allows you to build a resilient financial safety net that does not rely on the performance of a single, blended instrument that may fail to deliver on either front.
Nuance
Check Your Understanding
An analyst is evaluating an insurance-linked investment product for a high-net-worth client. Which action best reflects the principle of decoupling insurance from investment?
Why does a combined insurance-investment product often receive a lower suitability score from a professional advisor compared to a separate term plan and mutual fund approach?
This is a companion read for Section 2.7 — Criteria to evaluate various life insurance products from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.